Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Yung

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Nature Communications|December 6, 2019
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4Zhiyong Wang, Victoria H Wu, Michael M Allevato, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Antigenic cancer persister cells survive direct T cell attackMichael X Wang, Brandon E Mauch, August F Williams, et al.
Nature Immunology|June 12, 2023
The GPCR-Gα<sub>s</sub>-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failureVictoria H Wu, Bryan S Yung, Farhoud Faraji, et al.
Nature Communications|July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapyRobert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
Nature Communications|July 25, 2022
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCCRobert Saddawi-Konefka, Aoife O'Farrell, Farhoud Faraji, et al.
ESMO Open|July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisS Camera, A Vogel, M Rimini, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Nature Communications|December 6, 2019
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4Zhiyong Wang, Victoria H Wu, Michael M Allevato, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2025
Antigenic cancer persister cells survive direct T cell attackMichael X Wang, Brandon E Mauch, August F Williams, et al.
Nature Immunology|June 12, 2023
The GPCR-Gα<sub>s</sub>-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failureVictoria H Wu, Bryan S Yung, Farhoud Faraji, et al.
Nature Communications|July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapyRobert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
Nature Communications|July 25, 2022
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCCRobert Saddawi-Konefka, Aoife O'Farrell, Farhoud Faraji, et al.
ESMO Open|July 6, 2026
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisS Camera, A Vogel, M Rimini, et al.
Pageof 8